Aurora Cannabis Inc. (ACB) closed at $9.05 in the latest trading session, marking a -1.95% move from the prior day. This change lagged the S&P 500's 0.88% gain on the day. Meanwhile, the Dow gained 0.55%, and the Nasdaq, a tech-heavy index, added 1.32%. Heading into today, shares of the company had lost 0.22% over the past month, outpacing the Medical sector's loss of 6.83% and lagging the S&P 500's gain of 3.96% in that time. Wall Street will be looking for positivity from ACB as it approaches its next earnings report date. In that report, analysts expect ACB to post earnings of -$0.04 per share. This would mark no growth from the year-ago period. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $61.42 million, up 382.06% from the year-ago period. ACB's full-year Zacks Consensus Estimates are calling for earnings of -$0.18 per share and revenue of $224.47 million. These results would represent year-over-year changes of -250% and +417.53%, respectively.